1. Home
  2. BOKF vs BIO Comparison

BOKF vs BIO Comparison

Compare BOKF & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOKF
  • BIO
  • Stock Information
  • Founded
  • BOKF 1910
  • BIO 1952
  • Country
  • BOKF United States
  • BIO United States
  • Employees
  • BOKF N/A
  • BIO N/A
  • Industry
  • BOKF Major Banks
  • BIO Biotechnology: Laboratory Analytical Instruments
  • Sector
  • BOKF Finance
  • BIO Industrials
  • Exchange
  • BOKF Nasdaq
  • BIO Nasdaq
  • Market Cap
  • BOKF 6.0B
  • BIO 6.2B
  • IPO Year
  • BOKF N/A
  • BIO N/A
  • Fundamental
  • Price
  • BOKF $94.42
  • BIO $226.40
  • Analyst Decision
  • BOKF Buy
  • BIO Strong Buy
  • Analyst Count
  • BOKF 11
  • BIO 4
  • Target Price
  • BOKF $112.20
  • BIO $330.50
  • AVG Volume (30 Days)
  • BOKF 184.3K
  • BIO 374.2K
  • Earning Date
  • BOKF 07-21-2025
  • BIO 07-31-2025
  • Dividend Yield
  • BOKF 2.42%
  • BIO N/A
  • EPS Growth
  • BOKF 26.68
  • BIO N/A
  • EPS
  • BOKF 8.72
  • BIO N/A
  • Revenue
  • BOKF $2,087,418,000.00
  • BIO $2,541,100,000.00
  • Revenue This Year
  • BOKF $5.98
  • BIO N/A
  • Revenue Next Year
  • BOKF $7.52
  • BIO $3.69
  • P/E Ratio
  • BOKF $10.83
  • BIO N/A
  • Revenue Growth
  • BOKF 7.09
  • BIO N/A
  • 52 Week Low
  • BOKF $85.08
  • BIO $215.38
  • 52 Week High
  • BOKF $121.58
  • BIO $387.99
  • Technical
  • Relative Strength Index (RSI)
  • BOKF 47.83
  • BIO 41.49
  • Support Level
  • BOKF $91.40
  • BIO $220.31
  • Resistance Level
  • BOKF $95.47
  • BIO $233.28
  • Average True Range (ATR)
  • BOKF 1.59
  • BIO 8.26
  • MACD
  • BOKF -0.19
  • BIO -1.40
  • Stochastic Oscillator
  • BOKF 35.12
  • BIO 16.29

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: